Michael Smith

Articles by Michael Smith

ROCKVILLE, Md. -- Afluria was approved today by the FDA as the sixth seasonal influenza vaccine on the U.S. market. Manufactured by Australia's CSL Limited, the company will produce about two million doses for this year's flu season.

This MedPage Today video features senior staff writer Michael Smith sitting down with Larry Pickering, M.D., an infectious diseases specialist at the CDC, and Janet Englund, M.D., of the University of Washington in Seattle, to discuss America?s day-care centers and how new vaccines attribute to a safer environment.

HYATTSVILLE, Md. -- The U.S. death rate fell to a historic low in 2004 and the life expectancy at birth hit a record high, according to the National Center for Vital Statistics here.

DENVER -- Andrew Speaker, the focus of the storm over extensively drug-resistant tuberculosis, will have surgery next month to remove part of his lung, doctors here announced.

PHILADELPHIA -- Asthma mortality rates are declining worldwide, largely due to increased use of inhaled corticosteroids to manage the disease. That was the conclusion of an international group of researchers, who presented data on world trends at a 2006 meeting here.

NEW YORK -- In front-page news articles on successive days, the New York Times accused Lilly of a campaign to promote off-label use of Zyprexa, its anti-psychotic medication, while systematically downplaying the drug's side effects. Lilly denied the allegations.

Latest Updated Articles